Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2315300
Max Phase: Preclinical
Molecular Formula: C13H15NOS2
Molecular Weight: 265.40
Molecule Type: Small molecule
Associated Items:
ID: ALA2315300
Max Phase: Preclinical
Molecular Formula: C13H15NOS2
Molecular Weight: 265.40
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 2-(Cyclohexyldisulfanyl)Benzo[D]Oxazole
Synonyms from Alternative Forms(1):
Canonical SMILES: c1ccc2oc(SSC3CCCCC3)nc2c1
Standard InChI: InChI=1S/C13H15NOS2/c1-2-6-10(7-3-1)16-17-13-14-11-8-4-5-9-12(11)15-13/h4-5,8-10H,1-3,6-7H2
Standard InChI Key: ZFQQIGKPWWFOBF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 265.40 | Molecular Weight (Monoisotopic): 265.0595 | AlogP: 4.90 | #Rotatable Bonds: 3 |
Polar Surface Area: 26.03 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.74 | CX LogD: 4.74 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.74 | Np Likeness Score: -0.91 |
1. DiRaimondo TR, Plugis NM, Jin X, Khosla C.. (2013) Selective inhibition of extracellular thioredoxin by asymmetric disulfides., 56 (3): [PMID:23327656] [10.1021/jm301775s] |
Source(1):